These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34433301)

  • 1. 5α-Reductase Inhibitors Are Associated with Reduced Risk of SARS-CoV-2 Infection: A Matched-Pair, Registry-Based Analysis.
    Lyon M; Li J; Cullen J; Milinovich A; Kattan M; Jehi L; Sharifi N; Klein EA
    J Urol; 2022 Jan; 207(1):183-189. PubMed ID: 34433301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy.
    Lazzeri M; Duga S; Azzolini E; Fasulo V; Buffi N; Saita A; Lughezzani G; Paraboschi EM; Hurle R; Nobili A; Cecconi M; Guazzoni G; Casale P; Asselta R;
    Minerva Urol Nephrol; 2022 Feb; 74(1):77-84. PubMed ID: 33439572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5α-Reductase inhibitors and risk of high-grade or lethal prostate cancer.
    Preston MA; Wilson KM; Markt SC; Ge R; Morash C; Stampfer MJ; Loda M; Giovannucci E; Mucci LA; Olumi AF
    JAMA Intern Med; 2014 Aug; 174(8):1301-7. PubMed ID: 24887392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5α-reductase inhibitors and the risk of bladder cancer in a large, population-based cohort.
    Dekalo S; McArthur E; Campbell J; Ordon M; Power N; Welk B
    Urol Oncol; 2023 Jan; 41(1):50.e11-50.e17. PubMed ID: 36319553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of 5-alpha-reductase inhibitors is safe and effective in men on active surveillance for prostate cancer.
    Finelli A; Komisarenko M; Martin LJ; Timilshina N; Jain K; Morris J; Zlotta A; Kulkarni G; Perlis N; van der Kwast T; Evans A; Ghai S; Fleshner N; Alibhai SMH; Hamilton RJ
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):69-76. PubMed ID: 32152437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 5α-reductase inhibitor and α-blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality.
    Van Rompay MI; Curtis Nickel J; Ranganathan G; Kantoff PW; Solomon KR; Lund JL; McKinlay JB
    BJU Int; 2019 Mar; 123(3):511-518. PubMed ID: 30216624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin Use and COVID-19 Infectivity and Severity in South Korea: Two Population-Based Nationwide Cohort Studies.
    Lee SW; Kim SY; Moon SY; Yoo IK; Yoo EG; Eom GH; Kim JM; Shin JI; Jeong MH; Yang JM; Yon DK
    JMIR Public Health Surveill; 2021 Oct; 7(10):e29379. PubMed ID: 34623311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes following SARS-CoV-2 infection in liver transplant recipients: an international registry study.
    Webb GJ; Marjot T; Cook JA; Aloman C; Armstrong MJ; Brenner EJ; Catana MA; Cargill T; Dhanasekaran R; García-Juárez I; Hagström H; Kennedy JM; Marshall A; Masson S; Mercer CJ; Perumalswami PV; Ruiz I; Thaker S; Ufere NN; Barnes E; Barritt AS; Moon AM
    Lancet Gastroenterol Hepatol; 2020 Nov; 5(11):1008-1016. PubMed ID: 32866433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen Deprivation Therapy in Men with Prostate Cancer Does Not Affect Risk of Infection with SARS-CoV-2.
    Klein EA; Li J; Milinovich A; Schold JD; Sharifi N; Kattan MW; Jehi L
    J Urol; 2021 Feb; 205(2):441-443. PubMed ID: 32897764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-alpha reductase inhibitor influences expression of androgen receptor and HOXB13 in human hyperplastic prostate tissue.
    Jung C; Park Y; Kim YR; Ryu SB; Kang TW
    Int Braz J Urol; 2013; 39(6):875-83. PubMed ID: 24456780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
    Ayodele O; Cabral HJ; McManus D; Jick S
    Clin Epidemiol; 2021; 13():661-673. PubMed ID: 34377032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of rhabdomyolysis from 5-α reductase inhibitors.
    Welk B; McArthur E; Ordon M; Dirk J; Dixon S; Garg AX
    Pharmacoepidemiol Drug Saf; 2018 Mar; 27(3):351-355. PubMed ID: 29368380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI characterization of the dynamic effects of 5α-reductase inhibitors on prostate zonal volumes.
    Truong H; Logan J; Turkbey B; Siddiqui MM; Rais-Bahrami S; Hoang AN; Pusateri C; Shuch B; Walton-Diaz A; Vourganti S; Nix J; Stamatakis L; Harris C; Chua C; Choyke PL; Wood BJ; Pinto PA
    Can J Urol; 2013 Dec; 20(6):7002-7. PubMed ID: 24331340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in periprostatic adipose tissue induced by 5α-reductase inhibitors.
    Taussky D; Barkati M; Campeau S; Zerouali K; Nadiri A; Saad F; Delouya G
    Andrology; 2017 May; 5(3):511-515. PubMed ID: 28296186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The risk of dementia with the use of 5 alpha reductase inhibitors.
    Welk B; McArthur E; Ordon M; Morrow SA; Hayward J; Dixon S
    J Neurol Sci; 2017 Aug; 379():109-111. PubMed ID: 28716218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-Specific Antigen Kinetics Following 5α-Reductase Inhibitor Treatment May Be a Useful Indicator for Repeat Prostate Biopsy.
    Heo JE; Koo KC; Hong SJ; Park SU; Chung BH; Lee KS
    Yonsei Med J; 2018 Mar; 59(2):219-225. PubMed ID: 29436189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of mental disorders with SARS-CoV-2 infection and severe health outcomes: nationwide cohort study.
    Jeon HL; Kwon JS; Park SH; Shin JY
    Br J Psychiatry; 2021 Jun; 218(6):344-351. PubMed ID: 33407954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-alpha-reductase Inhibitors for prostate cancer prevention.
    Wilt TJ; MacDonald R; Hagerty K; Schellhammer P; Kramer BS
    Cochrane Database Syst Rev; 2008 Apr; 2008(2):CD007091. PubMed ID: 18425978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality.
    Wallner LP; DiBello JR; Li BH; Van Den Eeden SK; Weinmann S; Ritzwoller DP; Abell JE; D'Agostino R; Loo RK; Aaronson DS; Horwitz RI; Jacobsen SJ
    Urology; 2018 Sep; 119():70-78. PubMed ID: 29906480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between ABO and Rh Blood Groups and SARS-CoV-2 Infection or Severe COVID-19 Illness : A Population-Based Cohort Study.
    Ray JG; Schull MJ; Vermeulen MJ; Park AL
    Ann Intern Med; 2021 Mar; 174(3):308-315. PubMed ID: 33226859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.